Gene diagnosis and clinical management of multiple endocrine neoplasia type 1 (MEN1)

Authors
Citation
N. Hai et S. Kosugi, Gene diagnosis and clinical management of multiple endocrine neoplasia type 1 (MEN1), BIOMED PHAR, 54, 2000, pp. 47S-51S
Citations number
25
Categorie Soggetti
Pharmacology & Toxicology
Journal title
BIOMEDICINE & PHARMACOTHERAPY
ISSN journal
07533322 → ACNP
Volume
54
Year of publication
2000
Supplement
1
Pages
47S - 51S
Database
ISI
SICI code
0753-3322(200006)54:<47S:GDACMO>2.0.ZU;2-2
Abstract
Identification of the MEN1 gene as a disease gene for multiple endocrine ne oplasia type 1 (MEN1) has made it possible to predict whether a family memb er of an MEN1 patient will suffer from the same disease. MEN1 mutations hav e been found in almost all cases with familial MEN1, but in fewer cases wit h sporadic MEN1. We analyzed MEN1 mutations in the largest number of Japane se MEN1 patients, 17 families and 21 sporadic cases, and found 54 MEN1 muta nt carriers and 30 non-carriers. Furthermore, we identified a MEN1 phenocop y: GH-secreting pituitary tumor and primary hyperparathyroidism, which deve lops at older ages. In this article, we discuss how to utilize MEN1 gene di agnostics for the clinical management of MEN1 patients and MEN1 mutation ca rriers. (C) 2000 Editions scientifiques et medicales Elsevier SAS.